Sorrento Therapeutics, Inc.
$17.7 M
SuperCom Ltd.
$13.8 M
Secondary/Follow-On
Sole Book-Runner
Opexa Therapeutics, Inc.
$19.4 M
Secondary/Follow-On
Sole Book-Runner
Vuzix Corporation
$8.1 M
Secondary/Follow-On
Sole Book-Runner
Box Ships, Inc.
$13.4 M
Secondary/Follow-On
Joint Book-Runner
Heat Biologics, Inc.
$27 M
IPO
Sole Book-Runner
xG Technologies, Inc.
$8.5 M
IPO
Joint Book-Runner
Oramed Pharmaceuticals, Inc.
$4.6 M
Registered Direct
Sole Book-Runner
Miller Energy Resources, Inc.
$7.2 M
Secondary/Follow-On
Joint Book-Runner
MedWorth Acquisition Corp.
$52.8 M
IPO
Co-Manager
Echo Therapeutics, Inc.
$12.5 M
Secondary/Follow-On
Sole Book-Runner
RCS Capital Corporation
$50 M
IPO
Co-Manager